XPO1 is a new target of homoharringtonine (HHT): Making NPMc(+) AML cells much more sensitive to HHT treatment. Xue J, Chu P, Gao W, Wang F, et al. Biochem Biophys Res Commun 2023;675:155-161.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xue J, Chu P, Gao W, Wang F, et al. XPO1 is a new target of homoharringtonine (HHT): Making NPMc(+) AML cells much more sensitive to HHT treatment. Biochem Biophys Res Commun 2023;675:155-161.
PMID: 37473530